Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Merck
Moodys
McKesson
Mallinckrodt
AstraZeneca

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CANNABIDIVARIN

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Cannabidivarin

Trial ID Title Status Sponsor Phase Summary
NCT02365610 A Study of GWP42006 in People With Focal Seizures - Part B Recruiting GW Research Ltd Phase 2 To investigate the potential antiepileptic effects of GWP42006 as add-on therapy in subjects with inadequately controlled focal seizures.
NCT02369471 A Study of GWP42006 in People With Focal Seizures - Part A Completed GW Research Ltd Phase 2 To evaluate the pharmacokinetics, safety and tolerability of GWP42006 compared with placebo, in the presence of other antiepileptic drugs (AEDs).
NCT03202303 Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Not yet recruiting United States Department of Defense Phase 2 This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.
NCT03202303 Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD) Not yet recruiting Montefiore Medical Center Phase 2 This trial aims to study the efficacy and safety of cannabidivarin (CBDV) in children with ASD.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Cannabidivarin

Condition Name

Condition Name for
Intervention Trials
Autism Spectrum Disorder 3
Focal Seizures 2
Epilepsy 2
Prader-Willi Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention Trials
Autism Spectrum Disorder 3
Disease 3
Child Development Disorders, Pervasive 3
Autistic Disorder 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cannabidivarin

Trials by Country

Trials by Country for
Location Trials
United Kingdom 3
Czech Republic 2
Spain 2
Poland 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for
Location Trials
New York 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cannabidivarin

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase Trials
Phase 2 5
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase Trials
Not yet recruiting 3
Recruiting 1
Active, not recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cannabidivarin

Sponsor Name

Sponsor Name for
Sponsor Trials
GW Research Ltd 3
Montefiore Medical Center 2
United States Department of Defense 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor Trials
Other 4
Industry 3
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
McKesson
Baxter
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.